No serious adverse events or adverse effects directly related to the study drug were reported during this study. None of the subjects discontinued participation secondary to side effects.
To the Editor: As a response to the increasing demand for dermatologic care and the geographic maldistribution of dermatologists, nonphysician clinicians (NPCs) (nurse practitioners and physician assistants) have become a significant component of the US dermatology workforce. 1,2 Recent studies have raised concerns that NPCs may at times deliver care at a higher cost. 3, 4 These concerns have intensified as private equity firms have entered the dermatology field and preferentially employed NPCs to increase profits. 5 The purpose of this study is to characterize recent trends in independent billing for dermatologic procedures by NPCs. Prior literature on NPCs in dermatology has been limited to studies of practice scope at single points in time. [1] [2] [3] We hypothesized that growth in common dermatologic services provided by NPCs would exceed that for dermatologists. To test this hypothesis, we used Medicare Provider Utilization and Payment Data to examine services provided by dermatologists and NPCs who independently billed Medicare for the 3 most common dermatologic procedures between 2012 and 2016: CPT codes 17000 (destruction of premalignant lesion), 17003 (destruction of 2-14 premalignant lesions), and 11100 (biopsy of single growth of skin and/or tissue). 3 We measured the number of clinicians, number of procedures independently billed, average numbers of procedures and patients per clinician, and average number of procedures per patient.
As shown in Tables I and II , the compound annual growth rates (CAGRs) of procedures independently billed by NPCs were 18% to 20%, which are much higher than those of dermatologists (2%). The share of procedures independently billed by NPCs increased from 10% in 2012 to 17% to 18% in 2016. This trend can be explained by 2 factors. First, the number of NPCs independently billing for these procedures grew faster (CAGR, 13%-16%) than the number of dermatologists (CAGR, 2%). Second, the average number of procedures billed per clinician remained constant for dermatologists (CAGR, 0%) but increased for NPCs (CAGR, 4%-7%), with the increase driven by more patients being served per NPC (CAGR, 4%-6%) rather than by NPCs performing more procedures per patient (0%). Moreover, an across-provider and within-procedure comparison (Table II) indicates that the differences between NPCs and dermatologists in terms of the average number of procedures and the average number of patients per clinician had shrunk for all 3 procedures. This study has 2 limitations. First, we cannot distinguish when NPCs provided fully independent care from when they independently provided care at the request of a dermatologist. Second, we used Medicare data, which might not be reflective of care provided outside the Medicare population.
We found a remarkable increase in the share of dermatologic procedures provided by NPCs between 2012 and 2016, which was due to more NPCs providing such care and more patients served per NPC on average. These trends are in contrast to the stable landscape of dermatologists. The increasingly important role played by NPCs in providing dermatologic care will likely have a profound implication on access and costs of medical dermatology going forward. Future research is warranted to explore the optimal balance of dermatologists and NPCs in the delivery of dermatologic care.
